Tasly Pharmaceutical Group Co. Ltd. (SHSE:600535) said it scraps plan to spin off BioPharm Unit for listing in Shanghai Star Market due to change in market environment.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.56 CNY | -2.71% |
|
-5.14% | -26.20% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.20% | 2.65B | |
+28.10% | 5.68B | |
-33.42% | 3.61B | |
-3.33% | 3.11B | |
-9.99% | 2.33B | |
+40.09% | 1.89B | |
+40.90% | 1.49B | |
-12.94% | 1.46B | |
+46.67% | 1.37B | |
-30.31% | 1.31B |
- Stock Market
- Equities
- 600535 Stock
- News Tasly Pharmaceutical Group Co., Ltd
- Tasly Pharmaceutical Group Scraps Plan to Spin Off BioPharm Unit for Listing